DCB News and Events
News
Follow us on our new DCB LinkedIn page!
A recent Cancer Currents Blog features a perspective by Dr. Michael Weinreich, a DCB program director: DNA from Ancient Viruses Helps Many Cancers Grow
A recent NCI Data Science News article features Human Tumor Atlas Network (HTAN) and Translational and Basic Science Research in Early Lesions (TBEL) Program-funded research: GammaGateR Helps Decipher Imaging Data
A recent NIH Research Matters article features DCB-funded research: Keto Diet Enhances Experimental Cancer Therapy in Mice
A recent NIH News in Health article includes a perspective from Christine Nadeau, a Program Director in DCB: When Cancer Spread
A recent NCI Data Science News article features Cancer Systems Biology Consortium (CSBC)-funded research: NCI Study Shows Promise of Machine Learning’s Role in Personalized Cancer Treatment
Upcoming Events
September 6, 2024
Participation Application Deadline: Human Tumor Atlas Network (HTAN) Data Jamboree
Individuals can submit an application to attend this event will explore new approaches to analyze and integrate single-cell and spatial omics data from HTAN.
September 12, 2024
Virtual Keynote Talk on Acquired Resistance to Cancer Therapies
Dr. Michael Gottesman (NCI) will give a public, virtual presentation focusing on treatment resistance in cancer during an Acquired Resistance to Therapy Network (ARTNet) event.
September 24, 2024 (11:00 - 12:00 pm ET)
Cancer AI Conversations: AI and Global Oncology
Drs. Samir Antani (National Library of Medicine) and Ajay Aggarwal (King's College London) will discuss the application of artificial intelligence (AI) in global cancer research during a webinar moderated by Dr. Judy Wawira Gichoya (Emory University School of Medicine).
September 24, 2024 (3:00 - 4:00 pm ET)
Pre-Application Webinar for RFA-CA-24-029: RNA Modifications Driving Oncogenesis (RNAMoDO)
NCI staff will provide orientation and programmatic guidance to potential applicants of RFA-CA-24-029 by explaining the goals and objectives of the RNAMoDO program and answering questions from attendees.
September 25, 2024 (11:00 - 12:00 pm ET)
NCI Data Science Seminar: NCI’s Clinical and Translational Data Commons - Your Resource for Cancer Discovery
Gina Kuffel and Steff Singleton (NCI Center for Biomedical Informatics and Information Technology) will showcase the newly launched Clinical and Translational Data Commons (CTDC).
September 25, 2024 (1:30 - 2:30 pm ET)
AI in IO: SITC-NCI Computational Immuno-Oncology Webinar - Predicting Drug Resistance and Drug Repurposing with Imaging-Based AI
Dr. James Zou (Stanford University) will discuss how imaging-based AI approaches that can closely analyze drug-specific structures and interactions are being developed to improve immunotherapy in a webinar moderated by Dr. C. 'Harris' Floudas (NCI).
October 15, 2024 (1:00 - 2:00 pm ET)
AI in IO: SITC-NCI Computational Immuno-Oncology Webinar - Rationalized Patient Match and Clinical Trial Design with Large/Moderate Language Models on EHR Data
Dr. Zhiyong Lou (NCBI) will describe advances in AI for analyzing electronic health record (EHR) data to better design immunotherapy clinical trials and more efficiently match potential patients in a webinar moderated by Dr. C. 'Harris' Floudas (NCI).